chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Unidentified side effect; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Unidentified side effect) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Unidentified side effect). At the time of the report, VACCINATION COMPLICATION (Unidentified side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medicines were reported. No treatment information were reported.
fleeting myalgias; Initial information was received on 12-Sep-2020 regarding an unsolicited valid non-serious case from a physician.  This case involves a an unknown demographic patient who experienced fleeting myalgias (myalgia), when received INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT].  Medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (batch number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious mild fleeting myalgias (myalgia) several weeks following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE.  The patient did not have other likely etiology or other associated signs or symptoms.  Relevant laboratory test results included (Severe acute respiratory syndrome coronavirus 2) SARS-CoV-2 test on an unknown date which was negative.  It was not reported if the patient received any corrective treatment.  The outcome of event fleeting myalgia's was unknown.  There will be no information available on the batch number for this case.
Patient called the pharmacy after leaving an urgent care on 03/31/21. She stated that she had received the Moderna COVID vaccine through our pharmacy on 03/19/21, and the day after broke out in an itchy rash. She also had a headache and a "static sound" in her ears. The rash continued to worsen and spread over her body until she "just could not take it anymore," and decided she needed to be seen. She received injectable dexamethasone, oral prednisone, and topical triamcinolone at the urgent care.
VACCINE ADMINISTERED 10 WEEKS AFTER THAWING; PATIENT IS ASYMPTOMATIC.
12/31 SYMPTOMS; fever, fatigue, body ache, chills. lasted for 1 week. Took tylenol the first day, helped alliviate fever.
Child w redness and extreme itching in R arm. No hives present. Mother notes no changes in behavior or condition. Recommended ice/cool compress and/ or children's Benadryl. SE of Benadryl reviewed w mother.
Pt received influenza vaccine 9/16/14 approx. 3 PM. Pt reports seeing rash/hives form on arms the following day, worsening as the days passed. The rash spread to both arms, chest, waist, back, itchy eyes. Pt came into pharmacy 9/21/14. No changes to medications. Pt sent to urgent care and received Rx for prednisone taper.
DIARRHEA; FACIAL RASH; NAUSEA; HEADACHE; This spontaneous report received from a patient concerned a 58 year old of unspecified sex. The patient's height, and weight were not reported. The patient's concurrent conditions included medication allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown and expiry date: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination.  The batch number was not reported and has been requested. No concomitant medications were reported.  On 09-APR-2021, the subject experienced diarrhea. On 09-APR-2021, the subject experienced facial rash.  On 09-APR-2021, the subject experienced nausea. On 09-APR-2021, the subject experienced headache. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride (Benadryl). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from diarrhea, facial rash, nausea, and headache on APR-2021. This report was non-serious.
Information has been received from a physician concerning a patient who was vaccinated by mouth with a 2.0 ml dose of rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human-bovine).  Concomitant vaccinations included a dose of diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid.  The physician reported that the patient subsequently developed a rash.  Unspecified medical attention was sought.  At the time of this report, the outcome was unknown.  Additional information has been requested.
Patient called pharmacy to complain of a red rash that developed below the site of injection on her left arm and on her back. She said rash was itchy, she was scratching and making her skin redder. I counseled to apply a cold pack, use Benadryl to stop the itch.
This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (soar throat) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (soar throat). At the time of the report, OROPHARYNGEAL PAIN (soar throat) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant therapy included oxygen. Treatment information was unknown.
Afebrile Complex Partial Seizure lasting 20 minutes with Todd's Paralysis of 6th and 7th Cranial nerves on right.  CBC, CMP, CRP, Electrolytes, EEG, LFT within normal limits.  CT Scan with Cerebral Atrophy including large lacunae in left frontal lobe; no acute bleed; no SOL.  Transferred from one hospital to another for Pediatric neurology.  Observed overnight with resolution of Todd's paralysis and discharged home the following day.
w/in 10min of vax-feet as if throat was swelling a little SOB;sx persisted for 30min;felt tickle in throat - cough x 10 days;
Raised bump; Itchy; Blanched; Rash below the injection site 2x2 in/Rash got bigger/Rash got flatter and paler; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Raised bump), PRURITUS (Itchy), PALLOR (Blanched) and INJECTION SITE RASH (Rash below the injection site 2x2 in/Rash got bigger/Rash got flatter and paler) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced SWELLING (Raised bump), PRURITUS (Itchy), PALLOR (Blanched) and INJECTION SITE RASH (Rash below the injection site 2x2 in/Rash got bigger/Rash got flatter and paler). On 14-Jan-2021, SWELLING (Raised bump) had resolved. On 18-Jan-2021, PRURITUS (Itchy), PALLOR (Blanched) and INJECTION SITE RASH (Rash below the injection site 2x2 in/Rash got bigger/Rash got flatter and paler) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 21-Jan-2021: No specific follow-up information recorded.
?Covid arm?, trouble swallowing, fever, stiff neck, headache, sore throat, nausea, diarrhea, fatigue, loss of taste and smell.
I only had a sore arm at the injection site for a couple of days; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non-healthcare professional) for a Pfizer sponsored program (167798). The reporter is the patient. A 52-year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: Unknown) as dose 1, single for covid-19 immunisation. The patient relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "I only had a sore arm at the injection site for a couple of days".  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
feel tired; slightly feverish; This case was reported by a consumer and described the occurrence of tiredness in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced tiredness and fever. On an unknown date, the outcome of the tiredness and fever were unknown.   It was unknown if the reporter considered the tiredness and fever to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this case. The age at the vaccination was not reported. The patient received dose of Shingrix vaccine and felt tired and slightly feverish. The reporter asked GlaxoSmithKline could anyone felt tired and slightly feverish after getting the Shingrix vaccine. The follow-up would not possible as no contact details were available.
Received 1st dose of Pfizer-BioNTech at approx. 10:00. While waiting in observation area for 15 minutes after vaccine, client started to feel dizzy and notified nurse. Client requested EMSA at this time. Client moved to the floor to lay down and legs were elevated. Client then reported numbness of the tongue. No swelling visualized. 02 via nonrebreather mask initiated at 10:21 and EMSA called at 10:25. BP monitored (130/82 at 10:23, 142/78 at 10:27, 130/81 at 10:37). Client reported the numbness in his tongue went away. EMSA arrived at 10:41 and transported by ambulance to hospital for further evaluation.
Headache, Myalgia, Arthralgia, Fever & NauseaVomiting Narrative: Chills, fever, headache, nausea, joint pain, fatigue
Monday - Moderately severe lethargy and muscle cramping. Slept 18 hours and drank only liquids. Tuesday - Lethargy gone, slight stomach cramping remained. Onset of hives. Today (Wednesday) - No cramping or lethargy, hives worsening to moderate.
After getting the vaccine during the day, i got sick that night and ran a temperature of 100. My arm swelled up and i still had a temperature the next day. I developed severe congestion and had to take Mucinex to prevent a chest infection. this went on for about five days. I developed a fever blister. I experienced weakness and malaise for 10 days. I've had RSV in the past and this was like I got it again though not quite as severe. I did not get medical care as I have to drive 20 miles to another town.  I don't know if I will get this vaccination again, the side effects are too bad. I felt I should report this as it lasted quite a while.
Patient reports a mild bruise with slight discoloration, approx. 2 inches in diameter, at the site of injection. Activities of daily living are not affected, no other adverse effects noted.
soreness and stiffness radiated up to the neck and shoulders; soreness and stiffness radiated up to the neck and shoulders; soreness and stiffness radiated up to the neck and shoulders; soreness and stiffness radiated up to the neck and shoulders; This case was reported by a consumer via call center representative and described the occurrence of pain in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th September 2020, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than 6 months after receiving Shingrix, the patient experienced pain, muscle stiffness, neck pain and shoulder soreness. On an unknown date, the outcome of the pain, muscle stiffness, neck pain and shoulder soreness were recovered/resolved.   It was unknown if the reporter considered the pain, muscle stiffness, neck pain and shoulder soreness to be related to Shingrix.  Additional details were provided as follows: The patient had reported the case for herself. The age at vaccination was not reported, however it could be 56 or 57 years. The patient received 1st dose in the upper left arm. The patient experienced muscle stiffness and soreness for 5 days after receiving the 1st dose of the Shingrix vaccine.  The patient also stated that the soreness and stiffness radiated up to the neck and shoulders. The reporter did not gave permission to follow-up with her health care professional. The reporter did not consent to follow-up.
-Really bad headache -Swollen troat -Chills -Fever -Dizziness  -Vomiting
Miscarriage.  I was 5 weeks pregnant at the time of the 2nd Pfizer COVID vaccine on 4/23/21.    On 4/22/21, the pregnancy was confirmed by Ob/Gyn through a blood test, urine sample, and ultrasound.  I was at the time and am a healthy 30 year old woman without pre-existing medical conditions or any conditions that would put me into a high-risk pregnancy category.  The estimated due date was 12/20/21.   Received 2nd COVID on 4/23/21.    At 3:30pm on 4/28/21, I began miscarrying the pregnancy.  On the same day at 4pm, I was at Ob/Gyn and they confirmed that the pregnancy was likely miscarrying through an ultrasound and blood tests.    IMPORTANT: On 4/28/21, the pregnancy measured exactly the same in size as it did on 4/22/21.  In other words, the pregnancy either STOPPED growing the SAME DAY it was confirmed or the EXTACT NEXT DAY, which was the day I received the 2ND COVID VACCINE.   I discussed with my Doctor wither to proceed with the 2nd Covid vaccine and it was suggested that while it hasn?t been tested extensively in pregnancy, it was thought to be safe.
Multi-tonal ringing in right ear ranging from soft to very loud, changing pitch frequently. It started shortly after my first shot and had subsided slightly, but got worse again after my booster in December 2021. Some days it is better than others, but it's always there and I also have some hearing sensitivity/sensitivity to certain sounds.
Expired Moderna was administered on 11/19/2021 lot# 046C21A. Offender was called back to the clinic and vital signs were taken and were WNL. Offender showed no s/s of any distress and when asked he states no s/s. Provider was notified and also Moderna manufacture and they will update with guidelines. Offender was release back to security.
Patient's wife called complaining that her husband was having muscle weakness and slurred speech and wasn't sure if it was related to the vaccines he received.
Patient said arm was painful the night after immunization. Visited Dr the next day, diagnosed with cellulitis around administration site. Prescribed antibiotic.
PATIENT RECIEVED SHOT MONDAY AFTERNOON, TUESDAY MORNING WOKE UP WITH FEVER, ARM WAS WARM TO THE TOUCH/PAINFUL, AND HAD BRUSING AROUND AREA OF SHOT. THE BRUSING HAS CONTINUED TO SPREAD DOWN AND AROUND THE ARM TO THE ELBOW.
No additional adverse events reported; administration of expired VAQTA; This spontaneous report was received from medical assistant and concerns a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.   On 19-APR-2022, the patient was vaccinated with an expired dose of Hepatitis A Vaccine, Inactivated (VAQTA) in dose of 1 ml, lot number: U004367 was confirmed to be valid, expiration date: 11-APR-2022 (route and site of administration were not reported) for prophylaxis (expired product administered).   No additional adverse event was reported (no adverse event).
severe leg pains; Heart palpitations; numbness; tingling; throat tightness; This is a spontaneous report received from a contactable reporter (nurse). The reporter is the patient.  A 30 year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), administered in arm right, administration date 30Sep2021 at 09:30 (Batch/Lot number: unknown) at the age of 30 years as dose 2, single for COVID-19 immunization. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: BNT162B2 (dose 1, single, Batch/Lot number: unknown, Location of injection: right arm), administration date: 09Sep2021, when the patient was 30 years old, for COVID-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 30Sep2021 09:30, outcome "recovered with sequelae," described as "severe leg pains;" PALPITATIONS (non-serious) with onset 30Sep2021 09:30, outcome "recovered with sequelae," described as "Heart palpitations;" HYPOAESTHESIA (non-serious) with onset 30Sep2021 09:30, outcome "recovered with sequelae," described as "numbness;" PARAESTHESIA (non-serious) with onset 30Sep2021 09:30, outcome "recovered with sequelae," described as "tingling;" THROAT TIGHTNESS (non-serious) with onset 30Sep2021 09:30, outcome "recovered with sequelae," described as "throat tightness." The events "severe leg pains," "heart palpitations," "numbness," "tingling," and "throat tightness" were evaluated at the emergency room visit. Therapeutic measures were not taken as a result of pain in extremity, palpitations, hypoaesthesia, paraesthesia, and throat tightness.  Additional information: The vaccination facility type was reported as the workplace clinic. The patient had no other vaccine in four weeks. There were no other medications in two weeks. The patient had no COVID-19 prior vaccination and was not tested for COVID-19 post vaccination. The patient had no known allergies.  The lot number for BNT162B2 was not provided and will be requested during follow up.
Lower back started hurting extremely bad. Could not get out of bed the next day, back still hurting throughout weekend, really bad. Going on Tuesday and my back still hurts pretty bad, but getting slowly better.
Information has been received from a nurse referring to an unspecified number of unspecified patients of unknown gender and age. The patients' pertinent medical history and drug reactions/allergies were not provided. On unknown dates the patients were vaccinated with improperly stored PROQUAD (Merck) (lot # M001152, expiration date 05-JUL-2017; lot# M004893, expiration date 23-JUL-2017) (strength, dose and route were not provided). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient has experienced bad dreams and hallucinations beginning a couple of days after this second injection of the Moderna vaccine
6 days after second shot, very bad headache & repeated vomiting, lessened over several days, but then same symptoms a week later, Consulted urgent care & PCP. Brain MRI (about 3 weeks after second shot) found active hemorrhage, admitted to hospital via ER, many tests then craniotomy a few days later. Discharged with home OT/PT after 1 week in hospital. Developed blood clot in leg, detected about 10 days after hospital discharge - blood thinners for 3 months. Multiple tests conducted to try to determine cause of hemorrhage/clot in brain.
Inc temp started @ 300PM; had sz approx 400PM; went to ER by squad; temp @ ER 105;
started experiencing a foggy mind right after the 1st vaccine.  We waited an extra week beyond the time when he qualified for the second dose.  After the 2nd dose, the fog got stronger.  It has been 3 days and there is very little sign of improvement.
24 hrs after vaccine administration, patient developed wheals on his trunk, face and upper extremities. Patient's parents also report periorbital edema symptoms improved in 24 hrs. Parents were advised to give BENADRYL on 9/6/12 if urticaria persisted.
Local reaction, circular redness 45mm X 50mm slight induration and slightly warm to the touch.
Redness and itchiness to chest and lower neck around nose as well as minor tongue swelling. I was vaccinated at 0710, waited my 15 minutes drove home ( 15 min) showered and then just before 9 am realized Inwas itchy. Checked chest area and had red blotches similar in pattern to an anaphylactic reaction I had a few years earlier to betadine exposure. The night of the vaccine Inwoke up with nasal congestion and rhinorhea, itchy ears and throat, watery eyes. This became worse throughout the following day where I continued benadryl 50mg q6 as well as alternating tylenol and ibuprofen for body aches
On 2/28/01 the pt rec'd Prevnar #1 and Varivax. The following day fussy, then at 5:30pm, stiffened, crossed arms, eyes rolled back.
At this time, the patient is not having an adverse event.  The patient mistakenly asked for a COVID vaccine and the Janssen COVID 19 vaccination was administered.   We then realized that the patient had missed an appointment for Shingrix the day before and realized the incorrect vaccination may have been administered. The patient was contacted and realized she asked for the wrong vaccination (she had been previously vaccinated with Moderna (2 doses) already. ) The primary care provider has been notified and she is scheduled to receive her Shingrix in 14 days.
Information has been received from a certified nurse midwife (CNM), concerning an 18 year old female patient, with hypersensitivity to aspirin that involved abdominal distress, who on 17-JUL-2007 was vaccinated IM in the left arm, with a dose of Gardasil (Lot #656372/0243U). Concomitant therapy included hormonal contraceptives (manufacturer unspecified. Within a couple of hours after the vaccination, she experienced pain and soreness of her left arm, though she had no difficulty with movement of the arm. She also stated that she felt feverish, and reported her temperature was 99.2F. At the time of this report, the patient had not recovered. The patient sought unspecified medical attention. Additional information has been requested.
No additional Adverse Event; Improperly stored VARIVAX was administered to a patient; This spontaneous report as received from a medical assistant refers to a 13 year old female patient. Information regarding patient's medical history and concomitant medications were not provided.   The reporter stated that on 05-AUG-2021, a temperature excursion of varicella virus vaccine live (Oka/Merck)(VARIVAX) occurred during one hour, at 14.98°C. On 03-SEP-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot # T040507 and expiration date 02-DEC-2022, for prophylaxis (strength, dose, and route of administration were not reported) ( product storage error). No additional Adverse Events reported.
Moderna vaccine was accidently administered instead of annual flu shot. No adverse events to report at this time.
This case was reported by a consumer via call center representative and described the occurrence of adverse reaction in a adult female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX (1st dose received on an unknown date. For tolerance refer: US2018139561). On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown. It was unknown if the reporter considered the adverse reaction to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient had more mild reactions, after receiving the 2nd dose in the series approximately three months later the 1st dose, no specific events or event description was provided. Limited information was reported, the reporter did not wish to complete the safety report and hence a follow up was discouraged. The reporter also stated that, she did not complain about the SHINGRIX and was very happy with her experience with the SHINGRIX vaccine.